Clinical trials verifying the consistency of AmoyDx Essential NGS Panel (Reversible Terminator Sequencing) with local tests
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务:
资源简介:
Interventions: Gold Standard:Histopathological diagnosis;Index test:AmoyDx Essential NGS Panel (Reversible Terminator Sequencing) Primary outcome(s): EGFR 20 insertion mutation;consistency Study Design: Factorial
创建时间:
2020-12-15




